Pharmaceutical companies facing more than 100 lawsuits in federal court over improperly labeled birth control pills want the plaintiffs to provide pre-discovery information linking their claimed injuries to the defendants’ products.
Pantheon and Endo Pharmaceutical subsidiary Vintage Pharmaceuticals filed the request Monday in a consolidated litigation over the contraceptive Cyclafem, which faced a recall over its packaging in 2011. According to the defendants, the motion for a “Lone Pine-style” order is aimed at weeding out plaintiffs with nonmeritorious claims.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
